APA

Francis C. W., Kessler C. M., Goldhaber S. Z., Kovacs M. J., Monreal M., Huisman M. V., Bergqvist D., Turpie A. G., Ortel T. L., Spyropoulos A. C., Pabinger I. & Kakkar A. K. (20160225). Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study. : Journal of thrombosis and haemostasis : JTH.

Chicago

Francis C W, Kessler C M, Goldhaber S Z, Kovacs M J, Monreal M, Huisman M V, Bergqvist D, Turpie A G, Ortel T L, Spyropoulos A C, Pabinger I and Kakkar A K. 20160225. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study. : Journal of thrombosis and haemostasis : JTH.

Harvard

Francis C. W., Kessler C. M., Goldhaber S. Z., Kovacs M. J., Monreal M., Huisman M. V., Bergqvist D., Turpie A. G., Ortel T. L., Spyropoulos A. C., Pabinger I. and Kakkar A. K. (20160225). Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study. : Journal of thrombosis and haemostasis : JTH.

MLA

Francis C W, Kessler C M, Goldhaber S Z, Kovacs M J, Monreal M, Huisman M V, Bergqvist D, Turpie A G, Ortel T L, Spyropoulos A C, Pabinger I and Kakkar A K. Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study. : Journal of thrombosis and haemostasis : JTH. 20160225.